Related Experiment Video
Updated: Feb 8, 2026
13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
18.1K
Tau in neurodegenerative disease.
Yong-Lei Gao1, Nan Wang2, Fu-Rong Sun1
1Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao 266071, China.
Annals of Translational Medicine
|June 29, 2018
Summary
Tau protein aggregates form neurofibrillary tangles in tauopathies like Alzheimer disease. Understanding tau
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Tau protein is central to neurodegenerative tauopathies, including Alzheimer disease (AD).
- Hyperphosphorylated and aggregated tau forms neurofibrillary tangles (NFTs), a hallmark of AD.
- MAPT gene mutations link dysfunctional tau to diseases like frontotemporal dementia with parkinsonism-17 (FTDP-17).
Purpose of the Study:
- To review the biochemical properties of tau protein.
- To elucidate the pathogenesis of tau-induced neurodegeneration.
- To discuss tau biomarkers and therapeutic strategies.
Main Methods:
- Literature review and synthesis of existing research on tau protein.
- Analysis of biochemical properties and pathological mechanisms of tau.
- Overview of current tau-related biomarkers and therapeutic approaches.
Main Results:
- Tau protein's role in forming intracellular inclusions in various tauopathies.
- NFTs composed of hyperphosphorylated tau are key pathological features.
- Genetic mutations in MAPT gene implicate tau dysfunction in disease.
Conclusions:
- Mechanisms of tau-induced neurodegeneration require further clarification.
- Tau pathology is a critical target for understanding and treating neurodegenerative diseases.
- Biomarkers and targeted therapies are advancing tauopathy treatment.
Related Concept Videos
01:16Kendall's Tau Test
1.2K
Kendall's tau test, also known as the Kendall rank coefficient test, is a nonparametric method for assessing association between two variables. This test is particularly useful for identifying significant correlations when the distributions of the sample and population are unknown. Developed in 1938 by the British statistician Sir Maurice George Kendall, the tau coefficient (denoted as τ) serves as a rank correlation coefficient, with values ranging from -1 to +1.
A τ value of +1 indicates...
A τ value of +1 indicates...
1.2K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
01:25Immunodeficiency Diseases
2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.4K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Alzheimer's Disease: Treatment
968
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
01:26Principles of Disease Surveillance
563
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563